Doxazosin Mesylate
Brand names: Cardura, Cardura Xl, Doxazosin Mesylate
At a glance
- Medicare prescriptions, 2024
- 1,620,789
- Medicare drug cost
- $26.2M
- Average cost per prescription
- $16.17
- Clinicians who prescribed it
- 54,113
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
CARDURA ® XL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
From the FDA-approved prescribing information (label dated May 2023). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Internal Medicine 28.7%
- Family Medicine 26.2%
- Nurse Practitioners 9.7%
- Cardiology 9.3%
- Nephrology (Kidney) 7.9%
- Urology 4.6%
- Physician Assistants 3.5%
- General Practice 3.4%
- Interventional Cardiology 2.4%
- Geriatric Medicine 1.4%
- Hospitalist 0.4%
- Endocrinology & Diabetes 0.4%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 11% from 2019 to 2024.
Biggest change by state since 2019
- Colorado +9%
- Maryland +7%
- Connecticut +4%
- Delaware +0%
- New Jersey +0%
- West Virginia (smallest change) −25%
- New Mexico (smallest change) −24%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 4 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Bryant Ranch Prepack
| Strength | Looks like | Imprint |
|---|---|---|
| 4 mg | white round tablet, 12 mm, scored to split in 2 | AC 358 |
Mylan Pharmaceuticals Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 1 mg | white oval tablet, 9 mm, scored to split in 2 | CARDURA 1 MG |
| 1 mg | white round tablet, 7 mm | CN1 PFIZER |
| 2 mg | yellow oval tablet, 9 mm, scored to split in 2 | CARDURA 2 MG |
| 2 mg | white oval tablet, 9 mm, scored to split in 2 | CN2 PFIZER |
| 4 mg | orange oval tablet, 12 mm, scored to split in 2 | CARDURA 4 MG |
| 4 mg | white diamond tablet, 12 mm, scored to split in 2 | CN4 PFIZER |
| 8 mg | green oval tablet, 12 mm, scored to split in 2 | CARDURA 8 MG |
| 8 mg | white oval tablet, 12 mm, scored to split in 2 | CN8 PFIZER |
Roerig
| Strength | Looks like | Imprint |
|---|---|---|
| 1 mg | white oval tablet, 9 mm, scored to split in 2 | CARDURA 1 MG |
| 1 mg | white round tablet, 7 mm | CN1 PFIZER |
| 2 mg | yellow oval tablet, 9 mm, scored to split in 2 | CARDURA 2 MG |
| 2 mg | white oval tablet, 9 mm, scored to split in 2 | CN2 PFIZER |
| 4 mg | orange oval tablet, 12 mm, scored to split in 2 | CARDURA 4 MG |
| 4 mg | white diamond tablet, 12 mm, scored to split in 2 | CN4 PFIZER |
| 8 mg | green oval tablet, 12 mm, scored to split in 2 | CARDURA 8 MG |
| 8 mg | white oval tablet, 12 mm, scored to split in 2 | CN8 PFIZER |
Viatris Specialty LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 4 mg | white round tablet, 9 mm | CXL 4 |
| 8 mg | white round tablet, 11 mm | CXL 8 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
2 recalls since 2020
- Jan 2026 · Unichem Pharmaceuticals USA Inc. · Class III
Tablets/Capsules Imprinted with Wrong ID - Dec 2024 · Viatris Inc · Class II
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.